Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03150173 · ClinicalTrials.gov registry record · Phase 2
Onsite Buprenorphine Treatment at Syringe Exchange Programs
A Phase 2 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 97
- Enrollment target
NCT03150173 is a Phase 2 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 97 participants.
The verdict
NCT03150173, a Phase 2 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 97 participants
- Enrollment target
Study Summary
This trial will recruit syringe exchange participants with opioid use disorder in New York City and test whether starting buprenorphine treatment at the syringe exchange program is more effective than referral to a community health center for buprenorphine treatment.
Interventions
- DRUG Buprenorphine
- BEHAVIORAL Onsite treatment
- BEHAVIORAL Enhanced referral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2019-01-02 |
| Est. Completion | 2024-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03150173
The ClinicalTrials.gov registry entry for NCT03150173 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Buprenorphine is the first listed.
NCT03150173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03150173 about?
NCT03150173 is a clinical study titled "Onsite Buprenorphine Treatment at Syringe Exchange Programs". This trial will recruit syringe exchange participants with opioid use disorder in New York City and test whether starting buprenorphine treatment at the syringe exchange program is more effective than referral to a community health center for buprenorphine treatment.
What is the current status of trial NCT03150173?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 97 participants. The study started on 2019-01-02. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT03150173?
The interventions under investigation include: Buprenorphine (DRUG), Onsite treatment (BEHAVIORAL), Enhanced referral (BEHAVIORAL).
Who is sponsoring clinical trial NCT03150173?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.